1
项与 CD19 CAR-T (Tongji Hospital Tongji Medical College of HUST) 相关的临床试验A clinical trial of anti-CD19 chimeric antigen receptor–modified T cells (Anti-CD19 CAR-T) therapy for relapsed, refractory and high-risk CD19+ B cell malignancies
100 项与 CD19 CAR-T (Tongji Hospital Tongji Medical College of HUST) 相关的临床结果
100 项与 CD19 CAR-T (Tongji Hospital Tongji Medical College of HUST) 相关的转化医学
100 项与 CD19 CAR-T (Tongji Hospital Tongji Medical College of HUST) 相关的专利(医药)
100 项与 CD19 CAR-T (Tongji Hospital Tongji Medical College of HUST) 相关的药物交易